Rare Cutaneous Malignancies in Skin of Color.
Journal
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
pubmed:
7
4
2022
medline:
7
6
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
There is a scarcity of information regarding the clinical characteristics of rare cutaneous malignancies in skin of color that has yet to be comprehensively explored. To review and compile the racial differences in epidemiology, clinical presentation, histology, treatments, and outcomes of 3 rare skin cancers: dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC). Several searches with keywords denoting specific skin cancer type and race were conducted on PubMed to complete this narrative review. We analyzed 50 sources that were relevant to the initial objective. The literature demonstrates that there are nuances in DFSP, MCC, and SC unique to African Americans, Asians/Pacific Islanders, and Hispanics that may differ significantly from Caucasian counterparts. African Americans consistently suffer from the worst clinical outcomes in all 3 rare cutaneous malignancies reviewed. Greater physician awareness and knowledge of the discussed racial differences is the preliminary step to address these disparities.
Sections du résumé
BACKGROUND
There is a scarcity of information regarding the clinical characteristics of rare cutaneous malignancies in skin of color that has yet to be comprehensively explored.
OBJECTIVE
To review and compile the racial differences in epidemiology, clinical presentation, histology, treatments, and outcomes of 3 rare skin cancers: dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC).
METHODS
Several searches with keywords denoting specific skin cancer type and race were conducted on PubMed to complete this narrative review.
RESULTS
We analyzed 50 sources that were relevant to the initial objective.
CONCLUSION
The literature demonstrates that there are nuances in DFSP, MCC, and SC unique to African Americans, Asians/Pacific Islanders, and Hispanics that may differ significantly from Caucasian counterparts. African Americans consistently suffer from the worst clinical outcomes in all 3 rare cutaneous malignancies reviewed. Greater physician awareness and knowledge of the discussed racial differences is the preliminary step to address these disparities.
Identifiants
pubmed: 35384892
doi: 10.1097/DSS.0000000000003440
pii: 00042728-202206000-00003
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
606-612Informations de copyright
Copyright © 2022 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Battie C, Gohara M, Verschoore M, Roberts W. Skin cancer in skin of color: an update on current facts, trends, and misconceptions. J Drugs Dermatol 2013;12:194–8.
Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol 2007;56:968–73.
Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, et al. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg 2016;42(Suppl 1):S24–31.
Kim M, Huh CH, Cho KH, Cho S. A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients. J Eur Acad Dermatol Venereol 2012;26:964–71.
Criscito MC, Martires KJ, Stein JA. Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans. JAMA Dermatol 2016;152:1365–71.
Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma protuberans. Dermatol Clin 2019;37:483–8.
Bowne WB, Antonescu CR, Leung DHY, Katz SC, et al. Dermatofibrosarcoma protuberans. Cancer 2000;88:2711–20.
Agbai ON, Buster K, Sanchez M, Hernandez C, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol 2014;70:748–62.
Escobar GF, Ribeiro C, Leite LL, Barone CR, et al. Dermoscopy of dermatofibrosarcoma protuberans: what do we know? Dermatol Pract Concept 2019;9:139–45.
Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, et al. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol 2013;30:13–28.
Rohrmann S, Nelson WG, Rifai N, Brown TR, et al. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab 2007;92:2519–25.
Marsh EE, Shaw ND, Klingman KM, Tiamfook-Morgan TO, et al. Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 2011;96:3199–206.
Kreicher KL, Honda KS, Kurlander DE, Bordeaux JS. Hormone receptor expression in patients with dermatofibrosarcoma protuberans. J Am Acad Dermatol 2016;75:1205–9.
Meng T, Shi X, Wu S, Luo Y, et al. Hormone receptors analysis in Chinese patients with dermatofibrosarcoma protuberans. J Surg Oncol 2018;118:157–66.
Trofymenko O, Bordeaux JS, Zeitouni NC. Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis. J Am Acad Dermatol 2018;78:1125–34.
Haas RL, Keus RB, Loftus BM, Rutgers EJ, et al. The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Eur J Cancer Oxf Engl 1997;33:1055–60.
Paulson KG, Park SY, Vandeven NA, Lachance K, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol 2018;78:457–63.
Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, et al. Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States. Am Surg 2015;81:802–6.
Harms KL, Healy MA, Nghiem P, Sober AJ, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the New 8th Edition AJCC staging system. Ann Surg Oncol 2016;23:3564–71.
Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010;37:20–7.
Stang A, Becker JC, Nghiem P, Ferlay J. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur J Cancer 2018;94:47–60.
Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003;49:832–41.
Freeman MB, Holman DM, Qin J, Lunsford NB. Merkel cell carcinoma incidence, trends, and survival rates among adults aged ≥50 years from United States Cancer Statistics. J Am Acad Dermatol 2019;80:1154–6.
Song PI, Liang H, Wei WQ, Jiang YQ, et al. The clinical profile of Merkel cell carcinoma in mainland China. Int J Dermatol 2012;51:1054–9.
Saito A, Tsutsumida A, Furukawa H, Saito N, et al. Merkel cell carcinoma of the face: an analysis of 16 cases in the Japanese. J Plast Reconstr Aesthet Surg 2009;62:1272–6.
Woo K-J, Choi Y-L, Jung HS, Jung G, et al. Merkel cell carcinoma: our experience with seven patients in Korea and a literature review. J Plast Reconstr Aesthet Surg 2010;63:2064–70.
Heath M, Jaimes N, Lemos B, Mostaghimi A, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375–81.
Sridharan V, Muralidhar V, Margalit DN, Tishler RB, et al. Merkel cell carcinoma: a population analysis on survival. J Natl Compr Cancer Netw 2016;14:1247–57.
Perman MJ, King JM, Leithauser LL, Gloster HM. Giant Merkel cell carcinoma masquerading as a benign cyst on the buttock of an African American man. Case Rep Oncol Med 2011;2011:1–2.
Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of Merkel cell carcinoma. Curr Probl Cancer 2010;34:14–37.
Martel-Jantin C, Filippone C, Tortevoye P, Afonso PV, et al. Molecular epidemiology of Merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol 2014;52:1687–90.
Lebbe C, Becker JC, Grob JJ, Malvehy J, et al. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer Oxf Engl 2015;51:2396–403.
Takagishi SR, Marx TE, Lewis C, Tarabadkar ES, et al. Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck. Adv Radiat Oncol 2016;1:244–51.
Strom T, Carr M, Zager JS, Naghavi A, et al. Radiation therapy is associated with improved outcomes in Merkel cell carcinoma. Ann Surg Oncol 2016;23:3572–8.
Trofymenko O, Zeitouni NC, Kurtzman DJ. Factors associated with advanced-stage Merkel cell carcinoma at initial diagnosis and the use of radiation therapy: results from the National Cancer Database. J Am Acad Dermatol 2018;79:680–8.
Madankumar R, Criscito MC, Martires KJ, Stein JA. A population-based cohort study of the influence of socioeconomic factors and race on survival in Merkel cell carcinoma. J Am Acad Dermatol 2017;76:166–7.
Ezaldein HH, Ventura A, DeRuyter NP, Yin ES, et al. Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in Merkel cell carcinoma: a surveillance, epidemiology, and end-results study. Oncoscience 2017;4:106–14.
Allen PJ, Bowne WB, Jaques DP, Brennan MF, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300–9.
Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009;115:158–65.
Kyllo RL, Brady KL, Hurst EA. Sebaceous carcinoma: review of the literature. Dermatol Surg 2015;41:1–15.
Tripathi R, Chen Z, Li L, Bordeaux JS. Incidence and survival of sebaceous carcinoma in the United States. J Am Acad Dermatol 2016;75:1210–5.
Dores GM, Curtis RE, Toro JR, Devesa SS, et al. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms. Cancer 2008;113:3372–81.
Ni C, Searl SS, Kuo PK, Chu FR, et al. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin 1982;22:23–61.
Lam SC, Li EY, Yuen HK. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management. Br J Ophthalmol 2018;102:1723–7.
Watanabe A, Sun MT, Pirbhai A, Ueda K, et al. Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes. Br J Ophthalmol 2013;97:1459–63.
Yoon JS, Kim SH, Lee CS, Lew H, et al. Clinicopathological analysis of periocular sebaceous gland carcinoma. Ophthalmologica 2007;221:331–9.
Shields JA, Demirci H, Marr BP, Eagle RC, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004;111:2151–7.
Zhou C, Shi Y, Chai P, Wu F, et al. Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinoma. EBioMedicine 2018;36:221–8.
Blake PW, Bradford PT, Devesa SS, Toro JR. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. Arch Dermatol 2010;146:625–32.
Park SK, Park J, Kim HU, Yun SK. Sebaceous carcinoma: clinicopathologic analysis of 29 cases in a tertiary hospital in Korea. J Korean Med Sci 2017;32:1351–9.